NSE : SUNPHARMA BSE : 524715 ISIN CODE : INE044A01036 Industry : Pharmaceuticals & Drugs House : Sun Pharma
Related News:
Sun Pharmaceutical: Buy, sell or hold? What should investors do after Q2 results?
Company Overview:
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.
Industry: Drug ManufacturersSpecialty & Generic
Sector: Healthcare
Website: http://www.sunpharma.com
Phone: 91 22 4324 4324
Management:
| Chairman | Israel Makov |
| Managing Director | Dilip S Shanghvi |
| Company Secretary | Sunil R Ajmera |
| Non Executive Independent Director | Rekha Sethi Vivek Chaand Sehgal Gautam Doshi Pawan Goenka Rama Bijapurkar |
| Whole Time Director | Sailesh T Desai Kalyanasundaram Subramanian |
| Non Independent & Non Executive Director | Sudhir V Valia |